November 20, 2012 — More than 570 providers identify McKesson, Merge, Philips and Siemens as the top vendors in terms of overall provider satisfaction and adoption, according to the recently released KLAS study, Cardiology IT 2012: Fitting the Pieces Together.


Medtronic Inc. announced the first treatment of a U.S. patient in its global, multicenter, randomized clinical trial comparing the Medtronic CoreValve system with surgical aortic valve replacement in patients with severe aortic stenosis who are at intermediate risk to undergo open-heart surgery. The Medtronic CoreValve Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial is evaluating the minimally-invasive CoreValve system in less-sick patients who typically are treated with open-heart surgical aortic valve replacement today.

Biotronik announced that high profile medical centers across the country are implanting the new Evia HF-T triple-chamber cardiac resynchronization therapy (CRT) pacemaker.


Ischemic heart disease affects nearly 10 million Americans, and remains the leading cause of death among U.S. adults. This condition is most often due to a build-up of fat or plaque in the heart’s arteries that can reduce critical blood flow to the heart and often other parts of the body as well. With appropriate medical care, this condition remains stable in the vast majority of patients with few or no symptoms and the ability to pursue normal activities without limitations. Still, ongoing medical therapy and careful monitoring are essential to prevent heart attack and untimely death and should be based on strong scientific evidence and individual patient preferences.


Cordis Corp. announced that the U.S. Food and Drug Administration (FDA) has approved the S.M.A.R.T. Control Vascular Stent Systems for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery (PPA). The S.M.A.R.T. Stent, which has been approved for peripheral indication in international markets since 1999, is now the first stent in the United States with both Iliac and SFA indications.

CardioNet Inc. announced the launch of its new wireless event monitor, wEvent.


The introduction of hybrid technology — positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography (SPECT)/CT -— has revolutionized the imaging world. This technology allows the combination of the exquisite anatomic details provided, for example, by CT, with the important and much needed functional, physiologic or metabolic information provided by molecular imaging. 


Subscribe Now